Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci. 2006 Nov; 97(11):1191-7.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Animals
Antibodies, Monoclonal
Biomarkers, Tumor
Carcinoma, Pancreatic Ductal
Cell Survival
Enzyme-Linked Immunosorbent Assay
Feasibility Studies
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genome, Human
Humans
Immunoenzyme Techniques
Immunoprecipitation
Lectins, C-Type
Mice
Mice, Inbred BALB C
Middle Aged
Neoplasm Proteins
Oligonucleotide Array Sequence Analysis
Pancreatectomy
Pancreatic Neoplasms
Pancreatitis-Associated Proteins
Proto-Oncogene Proteins c-akt
Rabbits
Recombinant Proteins
Reverse Transcriptase Polymerase Chain Reaction
RNA, Small Interfering
Tissue Array Analysis
authors with profiles
Yusuke Nakamura